AstraZeneca Stuck With FCA Case Over Crestor Marketing
A Delaware federal judge has refused to ax a False Claims Act suit accusing pharmaceutical giant AstraZeneca of fraudulently marketing its cholesterol-lowering drug Crestor, but agreed to toss one whistleblower from...To view the full article, register now.
Already a subscriber? Click here to view full article